𝗘𝘂𝗿𝗼𝘀𝗰𝗿𝗲𝗲𝗻𝗙𝗮𝘀𝘁 𝗶𝘀 𝗼𝗻𝗰𝗲 𝗮𝗴𝗮𝗶𝗻 𝗮𝘁𝘁𝗲𝗻𝗱𝗶𝗻𝗴 𝗗𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝘆 𝗼𝗻 𝗧𝗮𝗿𝗴𝗲𝘁 𝟮𝟬𝟮𝟰 𝗶𝗻 𝗕𝗼𝘀𝘁𝗼𝗻! From 30 September to 3 October, EuroscreenFast be exhibiting at Booth 423 - don’t miss the opportunity to connect with Laurent Meeus and Brett Whitecross and find out just how EuroscreenFast can support your GPCR drug discovery programs. Dr. Laurent Meeus will also be speaking on Thursday 3 October at 12:45 at the 𝟭𝟵𝘁𝗵 𝗔𝗻𝗻𝘂𝗮𝗹 𝗚𝗣𝗖𝗥-𝗕𝗮𝘀𝗲𝗱 𝗗𝗿𝘂𝗴 𝗗𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝘆 𝗰𝗼𝗻𝗳𝗲𝗿𝗲𝗻𝗰𝗲, part of the wider program, where he will give valuable insight into the assay development and screening of pH-activated GPCR receptors. Be sure to stop by if you're attending and meet with our experts and learn how EuroscreenFast has been pioneering GPCR science for over 30 years! 🦠 #GPCR | 🔬 #Biotechnology | 💡 #Innovation | ⚕️ #DrugDiscovery | 🌟 #EuroscreenFast | #BostonDOT24
EuroscreenFast’s Post
More Relevant Posts
-
📢 Only a few days until #ImmunoOnco24! We're excited to be part of this event and engage in discussions about immuno-oncology. Meet our expert, Alfred Akateh, onsite for insightful conversations. Don't miss this opportunity! 🌟 #immunology #oncology #biology #biotech #biosciences #biotechnology #scienceandtechnology #preclinicalresearch
We’re counting down the days till #ImmunoOnco24! Are you joining us this week for an incredible conference experience? Get all the details on the conference website https://lnkd.in/eDcM_KcM A huge thank you to our sponsors for making this edition possible! See you on Thursday! 👋 -- Beckman Coulter Life Sciences Standard BioTools WuXi AppTec Agilent Technologies BD Collaborative Drug Discovery - CDD Vault Concept Life Sciences Cyagen Lunaphore Mabtech Miltenyi Biotec MMI - Molecular Machines & Industries PEPperPRINT GmbH Sanbio B.V. Singleron Biotechnologies Tebubio Tecan Assay Genie Seqalis
To view or add a comment, sign in
-
-
🌟 A Unique Scientific Milestone in Cell-Based Assays! 🌟 We're excited to share an extraordinary video capturing U2OS-ACE2 cells infected with SARS-CoV-2 forming syncytia upon expression of Syncytin-1—all LABEL-FREE! 🧬🔬 This video is a scientific marvel, showcasing organelles segmented without any labels, providing an unprecedented view into cellular processes in real-time. Join us tomorrow for a special online event hosted by Nanolive SA. Mathieu Fréchin, the last author of the newly published paper in Nature Communications, featuring this remarkable video, will discuss the innovative methods and scientific insights that made this possible. 📅 Date: June 25th & 26th ⏰ Time: première at 4 pm CEST (four different options to best fit your time zone) 🔗 RSVP: https://bit.ly/459Dz1s Don't miss this unique opportunity to delve into the latest advancements in cell-based in vitro assays. See you there! #Biotech #Pharma #CellBasedAssays #SARSCoV2 #LabelFreeImaging #Nanolive #NatureCommunications #ScientificBreakthrough
To view or add a comment, sign in
-
Two months after ELRIG UK Drug Discovery, it’s great to see the conversations and insights continuing! At the event, we shared updates on our SITESEEKER screening platform, identifying novel druggable sites across the human proteome to advance future therapies. If you didn’t get the chance to stop by, check out our poster, “Uncovering New Pathways for Targeted Protein Degradation", highlighting SITESEEKER’s ability to target E3 ligases with small molecules for effective protein degradation. Read our poster on News Medical: https://lnkd.in/eAEnS_f6 #TPD #DegraderTherapeutics #ProteinDegradation
To view or add a comment, sign in
-
-
Exciting news from SBH Sciences! 💡 We're excited to share our updated company presentation, showcasing how SBH Sciences has assisted over 350 biotech companies globally over the last 27 years. Highlights include: ✅ Bringing 7 NCE's to clinical trials ✅ Comprehensive Cell-Based Products ✅ Advanced Bioanalytical Services ✅ Expert Cell Culture Services ✅ Specialized Protein Purification Services ✅ Valuable data insights Discover more about our products and services here: https://lnkd.in/eTmnyYjy #companypresentation #contractresearchorganizaton #biotech #natick #diagnostics
To view or add a comment, sign in
-
-
How can you generate data for 125,000 interactions from a fragment-based or target-focused small-molecule library…in just three days? Find out in our free webinar on December 11, 2024, to be hosted in collaboration with Carna Biosciences, Inc.. HT-SPR is a direct, label-free method that produces gold-standard, real-time kinetics for highly parallel interactions. In this webinar, we highlight the power of combining an extensive panel of biotinylated kinases with small-molecule fragment and target-focused libraries to generate a wealth of compound binding information that can augment the drug discovery process for this challenging class of drug targets. ➡ Register here and save your spot: https://bit.ly/3AlmBSQ #HTSPR #kinases #drugdiscovery #labelfree #webinar #smallmolecule #Carterra
To view or add a comment, sign in
-
-
Did you know a whopping 9️⃣0️⃣% of those who attended the live broadcast of our webinar - Go/No Go: Gaining mechanistic insights of toxicity using a human DILI MPS to inform decision making said they would be back for other webinars by CN Bio ? Check out the insightful discussion by Dr. Ovidiu Novac now available on demand to learn more about how to further de-risk your workflows with the PhysioMimix® DILI assay. Explore how: 🔵 Human Liver MPS recapitulates organ functionality 🔵 The PhysioMimix DILI assay can be leveraged to predict human risk 🔵 The assay helps identify different mechanisms of hepatotoxicity 🔵 MPS technology fits within your drug discovery & development pipeline 👉Watch full presentation at https://bit.ly/4fa0yx0
To view or add a comment, sign in
-
Discover cutting-edge solutions in structure-based drug discovery research. As leaders in protein science, we are able to offer "off-the-shelf", rapidly available fit-for-purpose proteins along with high-resolution structures. Our team's expertise in Cryo-EM allow us to consistently elucidate difficult structures and share them with our collaborators in short timelines. Our GPCR Toolbox allows to generate G-protein complexes rapidly, with 25+ constructs available and optionally scFv16 for stabilization. 🌍 G-protein toolbox as a universal tool for different GPCR classes ⬇️ Reduced price and timelines for structural solution as only the production of the receptor needs to be established ✅ Increasing chances of success - Visit our gallery now and expedite your R&D program with our available protein gallery! https://lnkd.in/enf-mR5G
To view or add a comment, sign in
-
Veronica Venafra now at #BITS2024. This presentation will explore how SignalingProfiler integrates multi-omics data to identify phenotypic hallmarks, facilitating new approaches in drug repurposing. #Bioinformatics #MultiOmics #DrugRepurposing
To view or add a comment, sign in
-
-
Join us at the OpenTox Virtual Conference 2024! Interesting new insights into Nitrosamine testing:
27.11.2024 | Today our Scientific Director Csaba Boglári, Ph.D. will give a talk at the Genotoxicity Session of the OpenTox Virtual Conference 2024: https://lnkd.in/dME8VH7s The presentation will include the latest testing results from our study conducted on Nitrosamines using miniaturized Ames assays. 📅 Register for the event here: https://lnkd.in/dbEXTpJb 🌐 For more information, materials and resources, please visit our website: https://www.xenometrix.ch/ 📧 Further inquiries can be sent to cbo@xenometrix.ch #Nitrosamines #GenotoxicImpurities #VirtualConference #OpenTox #Talk #Presentation #Discussion #ScienitficExchange #AmesMPF #MicroAmes6 #AmesTest #MiniaturizedAmesTest #Mutagenicity #BacterialReverseMutation #MetabolicActivation #EnhancedAmesTest #HamsterS9 #AcceptableIntake #EMA #FDA #Volatile #NonVolatile #Cytotoxicity #AdjustedProtocols #ResourceEfficientTesting #NAMs #LowestEffectiveConcentration #Sensitivity #Specificity
To view or add a comment, sign in
-
Beckman Coulter Life Sciences has launched the Cydem VT Automated Clone Screening System, a revolutionary high-throughput microbioreactor platform for automated top clone screening.
Cydem VT Automated Clone Screening System to accelerate drug discovery
pathologyinpractice.com
To view or add a comment, sign in